http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5793965-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ae6f93cf0d2fcbb3ee0a112758fbd95
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-95
filingDate 1980-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c66f93b280da25418f3dfdbd0d4df63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8903526f57093a96681d036c7f12f4e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f674aa19e76f049daf5304891c4ccb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0405c2ca2980d6e485fc80390b2625e7
publicationDate 1982-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5793965-A
titleOfInvention Novel trimethoxyquinazoline derivative
abstract NEW MATERIAL:The compound of formulaI[R is 1W5C lower alkyl, 3W7C cycloalkyl or (substituted) phenyl; X is O or S] or its acid addition salt. n EXAMPLE: 4-Amino-2-( 4-isopropylcarbamoyl-piperazin-1-yl )-6,7,8-trimethoxyquinazoline. n USE: A hypotensor. It has vasodilating activity based on α-adrenergic blocking and calcium antagonistoc activities. n PROCESS: The compound of formulaIis prepared by reacting 4-amino-2-piperazino-6,7,8-trimethoxyquinazoline of formula II (a novel compound) with an isocyanate or isothiocyanate of formula III in a solvent such as benzene at -20W +100°C. The compound of formula II can be prepared by the debenzylation of the compound of formula V obtained by the reaction of the compound of formula IV with benzylpiperazine. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1980-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13556715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414810431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236224666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70542065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411317346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21469349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236430835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420433552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226462132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75994

Total number of triples: 35.